Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 25: Cardiac Biomarker Analysis from the EARLY TAVR Trial
Author(s): Brian Lindman Added: 10 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in… View more

Vascular Disease and Surgery
NY Valves 25: Early Outcomes of TAVI Valve with Intra-Annular Leaflet Position
Author(s): Santiago Garcia Added: 7 months ago
New York Valves 2025 -Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss outcomes from an observational study investigating early outcomes of the Navitor self-expandable transcatheter valve with intra-annular leaflet position. Approximately 3,000 patients with severe, symptomatic aortic stenosis, high surgical risk and tricuspid anatomy were enrolled in the study and… View more

Intervention
NY Valves 25: Early Clinical and QoL Outcomes of the PASCAL System
Author(s): Santiago Garcia Added: 7 months ago
New York Valves 2025 - Early outcomes from an observational study with the PASCAL System show a 97% device success rate.Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss a novel TEER device system. This observational study investigated the use of the PASCAL Prescision system in over 2000 patients from the STS/ACC/TVT registry over a period of two years.Findings… View more

Intervention
London Valves 25: AltaValve EFS: Broad Applicability at One-Year Outcomes
Author(s): Vlasis Ninios Added: 2 months ago
PCR London Valves 2025 - Dr Vlasis Ninios (Interbalkan European Medical Center, GR) discusses one-year outcomes from the AltaValve Early Feasibility Study, evaluating a novel atrial fixation system for transcatheter mitral valve replacement in patients with severe mitral regurgitation.This prospective, single-arm, multicenter study enrolled high surgical risk patients with moderate to severe or… View more

Intervention
TCT 24: The EVOLVED Trial
Author(s): Marc Dweck Added: 1 year ago
TCT Conference 2024 - Clinical outcomes of early intervention in patients with asymptomatic aortic stenosis (AS) did not impact the composite primary outcome of all cause mortality and unplanned AS related hospitalisation.Dr Marc Dweck (University of Edinburgh, Edinburgh, UK) joins us in this short interview filmed onsite at TCT Conference to discuss the findings from EVOLVED (NCT03094143;… View more

Imaging & Diagnostics

Intervention
Early Heparin in STEMI Improves Artery Patency: HELP-PCI
Added: 3 months ago Source:  Transcatheter Academy
The optimal timing for administering unfractionated heparin (UFH) to patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) has been a topic of discussion. The HELP-PCI trial investigated whether pre-treatment with UFH at first medical contact (FMC) improves outcomes compared to administration in the catheterisation laboratory (Cath… View more

Anticoagulation

Guidelines & Statements
ABSORB: Final Outcomes With the Absorb Bioresorbable Vascular Scaffold
Author(s): David Power Added: 1 year ago
Outcomes investigating the Absorb bioresorbable vascular scaffold (BVS) in patients undergoing percutaneous coronary intervention showed more adverse ischaemic events through 5 years compared with cobalt-chromium everolimus-eluting stents. However, the period of excess risk ended at 3 years.In this short interview, Dr David Power (Mount Sinai Hospital, New York, US) discusses the final report… View more

Intervention

Prevention & Chronic Conditions
Roxy Senior is Professor of Clinical Cardiology at the National Heart and Lung Institute, Imperial College London and Consultant Cardiologist and Director of Echocardiography at the Royal Brompton Hospital, London and Northwick Park Hospital, Harrow. He is a clinician with a major interest in echocardiography. He has been involved with echocardiography for the last 25 years and has published… View more
Validation of the MIRACLE2 Score
Author(s): Nicholas Sunderland , Francine Cheese , Zoe Leadbetter , et al Added: 2 years ago

Electrophysiology & Arrhythmia

MI/ACS
A Thorough Review of the Latest ACURATE neo2 Clinical Data
Author(s): Joanna J Wykrzykowska , Holger Thiele , Helge Möllmann Added: 1 year ago
In this insightful interview, Dr Joanna J Wykrzykowska (University of Groningen, Groningen, NL), Prof Holger Thiele (Heart Center Leipzig at University of Leipzig, Leipzig, DE), and Prof Helge Möllmann (St Johannes Hospital, Dortmund, DE) discuss the findings and implications of the PROVE Registry, a comprehensive multi-centre all-comers study focused on the ACURATE neo2 transcatheter aortic… View more

Intervention